BigHat Biosciences (Series B)
Funding Details
Awarder
Inbox
Date Award
July 20, 2022
Vertical
Biotechnology
Funding Amount
$75,000,000
Company Info
Founding Year
2019
Traction
BigHat has raised $105 million to date and is succeeding in partnerships with large biopharma partners.
Market
Human health
Location
San Mateo, California, USA
Coinvestors
8VC, AME Cloud Ventures, Amgen Ventures, Bristol-Myers Squibb, Gaingels, GRIDS Capital, Quadrille Capital
Company Description

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.